Trial Profile
Effect of Ramosetron on Postoperative Restoration of Bowel Motility After Gynecological Laparoscopic Surgery
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 07 Jan 2019
Price :
$35
*
At a glance
- Drugs Ramosetron (Primary)
- Indications Postoperative nausea and vomiting
- Focus Therapeutic Use
- 11 Jan 2017 Status changed from not yet recruiting to recruiting.
- 01 Aug 2016 New trial record